Myriad Genetic Launches Direct-to-Consumer Advertising Of Breast Cancer Gene Test In Northeastern Cities

Myriad Genetic Laboratories on Monday began a direct-to-consumer advertising campaign in Boston; Hartford, Conn.; New York City; and Providence, R.I., of its genetic test, BRCAnalysis, which identifies the BRCA1 and BRCA2 genetic mutations, the Wall Street Journal reports. [click link for full article]

More: continued here

Filed under: Cancer on September 13th, 2007